Telemis International has acquired Micromedica Ltd.
Begium-based Telemis International, a specialist in medical imaging solutions, has consolidated its position in Italy by acquiring Turin-based Micromedica Ltd, one of the country’s leading PACS (picture archiving and communication system) vendors. Financial details have not been disclosed.
Telemis extended its operations into Italy in 2009 with the opening of Telemis Italia SRL. The acquisition of Micromedica, in line with the company's strategy to support the growth of the PACS and MACS (multimedia archiving & communication system) markets in Europe, will significantly strengthen the sales and technical support capabilities offered to Italian customers.
Micromedica has specialized in the storage and management of radiology images since it was founded (as ERRE PI) in 1975. Since then the company has built an extensive base of customers including some of Northern Italy’s largest public hospitals. After the acquisition, Gian Paolo Robutti, Micromedica's Managing Director, takes the position of General Manager for Telemis in Italy.
Oaklins' team in Italy assisted the Italian subsidiary of Telemis throughout the negotiations.
Talk to the deal team
Related deals
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moreAfric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more